Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study
Xiaoxiao Zhao,1,* Li Song,1,* Jiannan Li,1 Jinying Zhou,1 Nan Li,1 Shaodi Yan,2 Runzhen Chen,1 Ying Wang,1 Chen Liu,1 Peng Zhou,1 Zhaoxue Sheng,1 Yi Chen,1 Hanjun Zhao,1 Hongbing Yan2 1Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-01-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/effect-of-triglyceride-glucose-indices-and-circulating-pcsk9-associate-peer-reviewed-fulltext-article-JIR |
| _version_ | 1797944643054206976 |
|---|---|
| author | Zhao X Song L Li J Zhou J Li N Yan S Chen R Wang Y Liu C Zhou P Sheng Z Chen Y Zhao H Yan H |
| author_facet | Zhao X Song L Li J Zhou J Li N Yan S Chen R Wang Y Liu C Zhou P Sheng Z Chen Y Zhao H Yan H |
| author_sort | Zhao X |
| collection | DOAJ |
| description | Xiaoxiao Zhao,1,* Li Song,1,* Jiannan Li,1 Jinying Zhou,1 Nan Li,1 Shaodi Yan,2 Runzhen Chen,1 Ying Wang,1 Chen Liu,1 Peng Zhou,1 Zhaoxue Sheng,1 Yi Chen,1 Hanjun Zhao,1 Hongbing Yan2 1Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongbing Yan, Fuwai Hospital, Chinese Academy of Medical Sciences, 12 Langshan Road, Shenzhen, 518000, People’s Republic of China, Tel +86-13701339287, Email hbyanfuwai2018@163.com Hanjun Zhao, Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 167, Beijing, 100037, People’s Republic of China, Tel +86-15210020808, Email 15210020808@163.comBackground and Aims: This study aimed to determine whether convertase subtilisin/kexin type 9 (PCSK9)-associated cardiovascular risk is modulated by triglyceride-glucose (TyG) in ST-segment elevation myocardial infarction (STEMI) patients with primary percutaneous coronary disease (PCI).Methods: A total of 1541 patients with STEMI (aged ≥ 18 years) undergoing primary PCI were consecutively enrolled between March 2017 and March 2019.Outcomes: When stratifying the overall population according to TyG indices less than or greater than the median (TyG median = 9.07) as well as according to quartiles of PCSK9 levels, higher TyG index levels were significantly associated with all-cause mortality only when TyG levels were 9.07 or higher (ie, relative to quartile 1 [Q1], the adjusted HR for all-cause mortality was 3.20 [95% CI, 0.54– 18.80] for Q2, p = 0.199; 7.89 [95% CI, 1.56– 40.89] for Q3, p = 0.013; and 5.61 [95% CI, 1.04– 30.30] for Q4, p = 0.045. During a median follow-up period of 1.96 years, the HR for all-cause mortality was higher in the subset of patients with TyG ≥median and PCSK9 ≥median (p for trend = 0.023) among those with type 2 diabetes mellitus (T2DM). However, there were no statistically significant differences among the subgroups. Among T2DM patients with a TyG index greater than the median, the Kaplan-Meier curve showed that patients with the highest PCSK9 levels had an increased risk of all-cause mortality (log-rank p = 0.017) and cardiac-cause mortality (log-rank p = 0.037) compared with lower PCSK9 quartile levels.Conclusion: Elevated PCSK9 levels are related to all-cause mortality and cardiac-related mortality when TyG levels are greater than the median, but not when levels are less than the median. This suggests a potential benefit of lowering circulating PCSK9 levels in STEMI patients with insulin resistance.Keywords: triglyceride glucose index, proprotein convertase subtilisin/kexin type 9, mortality, type 2 diabetes, ST-segment elevation myocardial infarction, primary percutaneous coronary intervention |
| first_indexed | 2024-04-10T20:43:00Z |
| format | Article |
| id | doaj.art-b6a5aaf11eb74a6c91a723db4b781070 |
| institution | Directory Open Access Journal |
| issn | 1178-7031 |
| language | English |
| last_indexed | 2024-04-10T20:43:00Z |
| publishDate | 2023-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Inflammation Research |
| spelling | doaj.art-b6a5aaf11eb74a6c91a723db4b7810702023-01-24T18:10:57ZengDove Medical PressJournal of Inflammation Research1178-70312023-01-01Volume 1626928281144Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort StudyZhao XSong LLi JZhou JLi NYan SChen RWang YLiu CZhou PSheng ZChen YZhao HYan HXiaoxiao Zhao,1,* Li Song,1,* Jiannan Li,1 Jinying Zhou,1 Nan Li,1 Shaodi Yan,2 Runzhen Chen,1 Ying Wang,1 Chen Liu,1 Peng Zhou,1 Zhaoxue Sheng,1 Yi Chen,1 Hanjun Zhao,1 Hongbing Yan2 1Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongbing Yan, Fuwai Hospital, Chinese Academy of Medical Sciences, 12 Langshan Road, Shenzhen, 518000, People’s Republic of China, Tel +86-13701339287, Email hbyanfuwai2018@163.com Hanjun Zhao, Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 167, Beijing, 100037, People’s Republic of China, Tel +86-15210020808, Email 15210020808@163.comBackground and Aims: This study aimed to determine whether convertase subtilisin/kexin type 9 (PCSK9)-associated cardiovascular risk is modulated by triglyceride-glucose (TyG) in ST-segment elevation myocardial infarction (STEMI) patients with primary percutaneous coronary disease (PCI).Methods: A total of 1541 patients with STEMI (aged ≥ 18 years) undergoing primary PCI were consecutively enrolled between March 2017 and March 2019.Outcomes: When stratifying the overall population according to TyG indices less than or greater than the median (TyG median = 9.07) as well as according to quartiles of PCSK9 levels, higher TyG index levels were significantly associated with all-cause mortality only when TyG levels were 9.07 or higher (ie, relative to quartile 1 [Q1], the adjusted HR for all-cause mortality was 3.20 [95% CI, 0.54– 18.80] for Q2, p = 0.199; 7.89 [95% CI, 1.56– 40.89] for Q3, p = 0.013; and 5.61 [95% CI, 1.04– 30.30] for Q4, p = 0.045. During a median follow-up period of 1.96 years, the HR for all-cause mortality was higher in the subset of patients with TyG ≥median and PCSK9 ≥median (p for trend = 0.023) among those with type 2 diabetes mellitus (T2DM). However, there were no statistically significant differences among the subgroups. Among T2DM patients with a TyG index greater than the median, the Kaplan-Meier curve showed that patients with the highest PCSK9 levels had an increased risk of all-cause mortality (log-rank p = 0.017) and cardiac-cause mortality (log-rank p = 0.037) compared with lower PCSK9 quartile levels.Conclusion: Elevated PCSK9 levels are related to all-cause mortality and cardiac-related mortality when TyG levels are greater than the median, but not when levels are less than the median. This suggests a potential benefit of lowering circulating PCSK9 levels in STEMI patients with insulin resistance.Keywords: triglyceride glucose index, proprotein convertase subtilisin/kexin type 9, mortality, type 2 diabetes, ST-segment elevation myocardial infarction, primary percutaneous coronary interventionhttps://www.dovepress.com/effect-of-triglyceride-glucose-indices-and-circulating-pcsk9-associate-peer-reviewed-fulltext-article-JIRtriglyceride glucose indexproprotein convertase subtilisin/kexin type 9mortalitytype 2 diabetesst-segment elevation myocardial infarctionprimary percutaneous coronary intervention |
| spellingShingle | Zhao X Song L Li J Zhou J Li N Yan S Chen R Wang Y Liu C Zhou P Sheng Z Chen Y Zhao H Yan H Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study Journal of Inflammation Research triglyceride glucose index proprotein convertase subtilisin/kexin type 9 mortality type 2 diabetes st-segment elevation myocardial infarction primary percutaneous coronary intervention |
| title | Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study |
| title_full | Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study |
| title_fullStr | Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study |
| title_full_unstemmed | Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study |
| title_short | Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study |
| title_sort | effect of triglyceride glucose indices and circulating pcsk9 associated cardiovascular risk in stemi patients with primary percutaneous coronary artery disease a prospective cohort study |
| topic | triglyceride glucose index proprotein convertase subtilisin/kexin type 9 mortality type 2 diabetes st-segment elevation myocardial infarction primary percutaneous coronary intervention |
| url | https://www.dovepress.com/effect-of-triglyceride-glucose-indices-and-circulating-pcsk9-associate-peer-reviewed-fulltext-article-JIR |
| work_keys_str_mv | AT zhaox effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT songl effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT lij effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT zhouj effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT lin effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT yans effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT chenr effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT wangy effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT liuc effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT zhoup effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT shengz effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT cheny effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT zhaoh effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy AT yanh effectoftriglycerideglucoseindicesandcirculatingpcsk9associatedcardiovascularriskinstemipatientswithprimarypercutaneouscoronaryarterydiseaseaprospectivecohortstudy |